{"id":"W2141111992","doi":"10.1056/nejmoa0706383","title":"B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2399,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"GlaxoSmithKline; Biogen; Eisai; Sanofi; Teva Pharmaceutical Industries; Genentech; AstraZeneca","keywords":"Medicine; Rituximab; Placebo; Multiple sclerosis; Internal medicine; Gastroenterology; Adverse effect; Clinical endpoint; CD20; Magnetic resonance imaging; Relapsing remitting; Surgery; Clinical trial; Immunology; Pathology; Lymphoma; Radiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07419576150057383,"score_gpt":0.2794389112804177,"score_spread":0.2052431497798439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}